We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $369M Turnover 0%
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+50.95%
3 Year Est. Return
+94.54%
5 Year Est. Return
+93.1%
10 Year Est. Return
+271.31%
AUM
$369M
AUM Growth
+$19.8M
Cap. Flow
-$5.47M
Cap. Flow %
-1.48%
Top 10 Hldgs %
60.59%
Holding
41
New
–
Increased
4
Reduced
18
Closed
–
Avg Time Held
7 years
Top 10 Avg Time Held
5.3 years
Top 20 Avg Time Held
6.9 years

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$2.4M
2
BBNX icon
Beta Bionics
BBNX
+$1.37M
3
FATE icon
Fate Therapeutics
FATE
+$370K
4
AER icon
AerCap
AER
+$213K

Top Sells

Rank Stock Value
1
VICR icon
Vicor
VICR
+$4.64M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$1.74M
3
ALL icon
Allstate
ALL
+$652K
4
AAPL icon
Apple
AAPL
+$572K
5
NEE icon
NextEra Energy
NEE
+$543K

Sector Composition

Rank Sector Weight
1 Healthcare 29.37%
2 Utilities 21.42%
3 Industrials 18.52%
4 Financials 8.53%
5 Technology 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ABBV icon
1
AbbVie
ABBV
$500B
$30.4M 8.24%
121,000
-1,500
-1% -$323K
2013 Q2
52 quarters
ALL icon
2
Allstate
ALL
$62.4B
$29.1M 7.89%
122,500
-3,000
-2% -$652K
2013 Q2
52 quarters
AER icon
3
AerCap
AER
$22.8B
$27M 7.3%
185,000
+1,500
+0.8% +$213K
2024 Q3
7 quarters
NEE icon
4
NextEra Energy
NEE
$163B
$25.8M 6.99%
294,300
-6,000
-2% -$543K
2013 Q2
52 quarters
MRK icon
5
Merck
MRK
$354B
$24.5M 6.64%
190,800
-2,000
-1% -$234K
2013 Q2
52 quarters
UHAL.B icon
6
U-Haul Holding Co Series N
UHAL.B
$9.6B
$24.1M 6.51%
417,000
-35,000
-8% -$1.74M
2022 Q4
14 quarters
DUK icon
7
Duke Energy
DUK
$93B
$18.3M 4.96%
144,816
-1,000
-0.7% -$126K
2014 Q3
47 quarters
VICR icon
8
Vicor
VICR
$8.79B
$18.2M 4.93%
48,000
-17,000
-26% -$4.64M
2023 Q3
11 quarters
XEL icon
9
Xcel Energy
XEL
$46.9B
$14.7M 3.97%
182,500
-2,000
-1% -$160K
2013 Q2
52 quarters
CMS icon
10
CMS Energy
CMS
$21.1B
$11.7M 3.17%
153,000
-3,000
-2% -$225K
2014 Q3
47 quarters
T icon
11
AT&T
T
$159B
$10.7M 2.9%
518,000
-5,000
-1% -$124K
2022 Q1
17 quarters
AAPL icon
12
Apple
AAPL
$5T
$10.7M 2.89%
36,900
-2,000
-5% -$572K
2018 Q1
33 quarters
BBNX icon
13
Beta Bionics
BBNX
$908M
$10.4M 2.82%
665,700
+115,000
+21% +$1.37M
2026 Q1
1 quarter
IIIN icon
14
Insteel Industries
IIIN
$572M
$10.4M 2.81%
343,423
– –
2022 Q3
15 quarters
ABT icon
15
Abbott
ABT
$180B
$10.2M 2.76%
112,300
-1,500
-1% -$137K
2013 Q2
52 quarters
NEM icon
16
Newmont
NEM
$124B
$9.34M 2.53%
100,000
– –
2019 Q2
28 quarters
AVA icon
17
Avista
AVA
$3.03B
$8.18M 2.21%
200,000
-1,500
-0.7% -$61.7K
2014 Q3
47 quarters
ADM icon
18
Archer Daniels Midland
ADM
$38.8B
$7.64M 2.07%
100,000
– –
2024 Q1
9 quarters
BG icon
19
Bunge Global
BG
$19.8B
$7.47M 2.02%
70,000
– –
2024 Q1
9 quarters
SUPN icon
20
Supernus Pharmaceuticals
SUPN
$2.32B
$6.98M 1.89%
150,000
+50,000
+50% +$2.4M
2014 Q2
48 quarters
PFE icon
21
Pfizer
PFE
$168B
$6.46M 1.75%
268,200
-3,700
-1% -$96.8K
2013 Q2
52 quarters
DAR icon
22
Darling Ingredients
DAR
$9.42B
$5.74M 1.55%
105,000
-1,000
-0.9% -$59.7K
2023 Q3
11 quarters
KOD icon
23
Kodiak Sciences
KOD
$5.74B
$5.65M 1.53%
145,000
– –
2023 Q1
13 quarters
CC icon
24
Chemours
CC
$1.9B
$5.13M 1.39%
250,000
– –
2025 Q1
5 quarters
UHAL icon
25
U-Haul Holding Co
UHAL
$10.8B
$4.75M 1.29%
72,600
-1,300
-2% -$71.3K
2013 Q2
52 quarters
1
2

Similar funds

EW
Evexia Wealth Stevens Point, Wisconsin $369M AUM 26.67% 1-Year Est. Return
CCG
Ceeto Capital Group Coral Gables, Florida $369M AUM 34.8% 1-Year Est. Return
OG
Odyssey Group Lancaster, Pennsylvania $369M AUM
ACA
AYAL Capital Advisors Toronto, Ontario, Canada $370M AUM 52.93% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return
MLCM
M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return

Bruce & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Bruce & Co held 41 positions worth $369M, up 5.7% from $350M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Bruce & Co opened no new positions and made no exits, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co added most to Supernus Pharmaceuticals in Q2 2026, an estimated $2.4M increase.
  • Bruce & Co's biggest Q2 2026 reduction was Vicor, cutting an estimated $4.64M.
  • Bruce & Co's ten largest holdings make up 61% of its $369M portfolio in Q2 2026.
  • Bruce & Co opened 0 new positions and closed 0 in Q2 2026.
  • Bruce & Co's portfolio value rose 5.7% quarter-over-quarter to $369M.

Based on Bruce & Co's 13F filing for Q2 2026, filed 14 Aug 2026.